PD-1/PD-L1 inhibitors combined with chemotherapy as first-line treatment for advanced biliary tract cancer: a systematic review and meta-analysis. [PDF]
Geng H, Lu C, Wang S, Tian L.
europepmc +1 more source
Evaluation of possibly fabricated references in 500,000 science, engineering, and computing papers. [PDF]
Topaz M, Gupta P, Zhang Z, Peltonen LM.
europepmc +1 more source
Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world study. [PDF]
Kosaka H +25 more
europepmc +1 more source
Reply to Topaz and Bahl: Interpreting a post-2022 lexical shift in academic prose. [PDF]
Siler K.
europepmc +1 more source
NeuDiff Agent: a governed AI workflow for single-crystal neutron crystallography. [PDF]
Xiao Z, Zhang L, Zhang G, Wang X.
europepmc +1 more source
QTL mapping and genomic prediction of resistance to apple blotch (<i>Diplocarpon coronariae</i>). [PDF]
Jung M, Hänni B, Muranty H, Patocchi A.
europepmc +1 more source
The use of radiofrequency ablation for the treatment of lateral epicondylitis: a systematic review of the literature. [PDF]
Ali M +3 more
europepmc +1 more source
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre. [PDF]
Elbasan S +17 more
europepmc +1 more source

